ppanPersonalized Psychiatry and NeurologyPersonalized Psychiatry and Neurology2712-9179V. M. Bekhterev National Medical Research Centre for Psychiatry and Neurology of the Ministry of Health of the Russian Federation (Bekhterev NMRC PN)10.52667/2712-9179-2022-2-2-84-89ppan-55Research ArticleCASE REPORTGenetic Profiling of the Nitric Oxide Synthases’ System in a 55-Year-Old Woman with the Tension-Type Headache and Arterial Hypertension Phenotype: Case ReportAlyabyevaP. V.

Polina V. Alyabyeva

660022 Krasnoyarsk

Tel.: +7 (391) 228 06 28

polina-moscaleva@yandex.ruV.F. Voino-Yasenetsky Krasnoyarsk State Medical UniversityRussian Federation202215112022228489Copyright © Alyabyeva P.V., 20222022Alyabyeva P.V.Alyabyeva P.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jppn.ru/jour/article/view/55

The tension-type headache (TTH) and arterial hypertension (AH) phenotype is a common overlap syndrome in adult patients. A genetically determined disturbance of the nitric oxide (NO) synthesis system is actively considered as one of the important possible pathogenetic mechanisms for the development of this phenotype. Neuronal NO-synthase is expressed both in the brain, skeletal muscles, and in the vascular endothelium; therefore, single-nucleotide variants of the NOS1 gene, encoding this enzyme, are the most interesting, but insufficiently studied genetic biomarkers of the TTH and AH phenotype. The aim of the case report is to present the experience of using genetic profiling of the nitric oxide synthases’ system in a 55-year-old patient with treatment-resistant TTH and AH phenotype.

tension-type headachearterial hypertensioncomorbiditynitric oxidenNOSiNOSeNOSNOS1NOS2NOS3genetic biomarkerrs3782218rs7314935rs2779249rs2297518rs1799983rs2070744ReferencesAlyabyeva, P.V.; Chastina, O.V.; Shnayder, N.A.; Petrova, M.M.; Nasyrova, R.F. Tension-type headache and hypertension phenotype: myth or reality. The Siberian Journal of Clinical and Experimental Medicine 2022, 37(3), 29–40. (In Russian). DOI: 0.29001/2073-8552-2022-37-3-29-40Alyabyeva, P.V.; Chastina, O.V.; Shnayder, N.A.; Petrova, M.M.; Nasyrova, R.F. Tension-type headache and hypertension phenotype: myth or reality. The Siberian Journal of Clinical and Experimental Medicine 2022, 37(3), 29–40. (In Russian). DOI: 0.29001/2073-8552-2022-37-3-29-40Petrova, M.M.; Moskaleva, P.V.; Shnayder, N.A.; Nasyrova, R.F. Comorbidity of arterial hypertension and tension-type headache. Cardiology. 2020, 60, 132–140. (In Russian). DOI: 10.18087/cardio.2020.10.n1363Petrova, M.M.; Moskaleva, P.V.; Shnayder, N.A.; Nasyrova, R.F. Comorbidity of arterial hypertension and tension-type headache. Cardiology. 2020, 60, 132–140. (In Russian). DOI: 10.18087/cardio.2020.10.n1363Moskaleva, P.V.; Khramchenko, M.A.; Karpenkova, A.D.; Petrova, M.M.; Shnayder, N.A. Modern concepts about pathogenesis of the tension-type headache and mechanisms of development of the tension-type headache and arterial hypertension phenotype. Russ. Neurol. J. 2022, 27, 22–33. (In Russian). DOI: 10.30629/2658-7947-2022-27-2-22-33Moskaleva, P.V.; Khramchenko, M.A.; Karpenkova, A.D.; Petrova, M.M.; Shnayder, N.A. Modern concepts about pathogenesis of the tension-type headache and mechanisms of development of the tension-type headache and arterial hypertension phenotype. Russ. Neurol. J. 2022, 27, 22–33. (In Russian). DOI: 10.30629/2658-7947-2022-27-2-22-33Shnayder, N.; Petrova, M.; Moskaleva, P.; Shesternya, P.; Pozhilenkova, E.; Nasyrova, R. The Role of single-nucleotide variants of NOS1, NOS2, and NOS3 genes in the comorbidity of arterial hypertension and tension-type headache. Molecules 2021, 26, 1556. DOI: 10.3390/molecules26061556Shnayder, N.; Petrova, M.; Moskaleva, P.; Shesternya, P.; Pozhilenkova, E.; Nasyrova, R. The Role of single-nucleotide variants of NOS1, NOS2, and NOS3 genes in the comorbidity of arterial hypertension and tension-type headache. Molecules 2021, 26, 1556. DOI: 10.3390/molecules26061556Nasyrova, R.F.; Moskaleva, P.V.; Vaiman, E.E.; Shnayder, N.A.; Blatt, N.L.; Rizvanov, A.A. Genetic factors of nitric oxide’s system in psychoneurologic disorders. Int. J. Mol. Sci. 2020, 21, 1604. DOI: 10.3390/ijms21051604Nasyrova, R.F.; Moskaleva, P.V.; Vaiman, E.E.; Shnayder, N.A.; Blatt, N.L.; Rizvanov, A.A. Genetic factors of nitric oxide’s system in psychoneurologic disorders. Int. J. Mol. Sci. 2020, 21, 1604. DOI: 10.3390/ijms21051604Geller, D.A.; Lowenstein, C.J.; Shapiro, R.A.; Nussler, A.K.; Di Silvio, M.; Wang, S.C.; Nakayama, D.K.; Simmons, R.L.; Snyder, S.H.; Billiar, T.R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 1993, 90, 3491–3495. DOI: 10.1073/pnas.90.8.3491Geller, D.A.; Lowenstein, C.J.; Shapiro, R.A.; Nussler, A.K.; Di Silvio, M.; Wang, S.C.; Nakayama, D.K.; Simmons, R.L.; Snyder, S.H.; Billiar, T.R. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc. Natl. Acad. Sci. USA 1993, 90, 3491–3495. DOI: 10.1073/pnas.90.8.3491Hancock, D.B.; Martin, E.R.; Vance, J.M.; Scott, W.K. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease. Neurogenetics 2008, 9, 249–262. DOI: 10.1007/s10048-008-0137-1Hancock, D.B.; Martin, E.R.; Vance, J.M.; Scott, W.K. Nitric oxide synthase genes and their interactions with environmental factors in Parkinson’s disease. Neurogenetics 2008, 9, 249–262. DOI: 10.1007/s10048-008-0137-1NCBI. Available online: https://www.ncbi.nlm.nih.gov/snp/ (accessed on 15 October 2022).NCBI. Available online: https://www.ncbi.nlm.nih.gov/snp/ (accessed on 15 October 2022).Olesen, J.; Dodick, D.W.; Ducros, A.; Evers, S.; First, M.B.; Goadsby, P.J. The International Classification of Headache Disorders. Cephalalgia 2018, 38, 1–211. DOI: 10.1177/0333102417738202Olesen, J.; Dodick, D.W.; Ducros, A.; Evers, S.; First, M.B.; Goadsby, P.J. The International Classification of Headache Disorders. Cephalalgia 2018, 38, 1–211. DOI: 10.1177/0333102417738202Williams, B.; Mancia, G.; Spiering, W.; Agabiti Rosei, E.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; De Simone, G.; Dominiczak, A.; et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Hypertens 2018, 36, 1953–2041. DOI: 10.1093/eurheartj/ehy339Williams, B.; Mancia, G.; Spiering, W.; Agabiti Rosei, E.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; De Simone, G.; Dominiczak, A.; et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Hypertens 2018, 36, 1953–2041. DOI: 10.1093/eurheartj/ehy339Kobalava, Z.D.; Konradi, A.O.; Nedogoda, S. V.; Shlyakhto, E. V.; Arutyunov, G.P.; Baranova, E.I.; Barbarash, O.L.; Boitsov, S.A.; Vavilova, T. V.; Villevalde, S. V.; et al. Arterial hypertension in adults. Clinical guidelines. Russ. J. Cardiol. 2020, 25, 3786Kobalava, Z.D.; Konradi, A.O.; Nedogoda, S. V.; Shlyakhto, E. V.; Arutyunov, G.P.; Baranova, E.I.; Barbarash, O.L.; Boitsov, S.A.; Vavilova, T. V.; Villevalde, S. V.; et al. Arterial hypertension in adults. Clinical guidelines. Russ. J. Cardiol. 2020, 25, 3786Alyabyeva, P.V.; Chastina, O.V.; Petrova, M.M.; Lareva, N.V.; Garganeeva, N.P.; Chumakova, G.A.; Cherniaeva, M.S.; Shnayder, N.A. New Genetic Biomarkers of the Overlap Syndrome Tension-Type Headache and Arterial Hypertension. Genes 2022, 13, 1823. DOI: 10.3390/genes13101823Alyabyeva, P.V.; Chastina, O.V.; Petrova, M.M.; Lareva, N.V.; Garganeeva, N.P.; Chumakova, G.A.; Cherniaeva, M.S.; Shnayder, N.A. New Genetic Biomarkers of the Overlap Syndrome Tension-Type Headache and Arterial Hypertension. Genes 2022, 13, 1823. DOI: 10.3390/genes13101823Moskaleva, P.; Shnayder, N.; Petrova, M.; Kaskaeva, D.; Gavrilyuk, O.; Radostev, S.; Garganeeva, N.; Sharavii, V.; Vaiman, E.; Nasyrova, R. The Role of Single Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Development of the Phenotype of Migraine and Arterial Hypertension. Brain Sciences 2021, 11(6), 753. DOI: 10.3390/brainsci11060753Moskaleva, P.; Shnayder, N.; Petrova, M.; Kaskaeva, D.; Gavrilyuk, O.; Radostev, S.; Garganeeva, N.; Sharavii, V.; Vaiman, E.; Nasyrova, R. The Role of Single Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Development of the Phenotype of Migraine and Arterial Hypertension. Brain Sciences 2021, 11(6), 753. DOI: 10.3390/brainsci11060753Alaşehirli, B.; Akçalı, A.; Demiryürek, A.T.; Ö zel, A.; Erdal, M.E.; Neyal, M. Lack of Association Between the C276T Polymorphism of the Neuronal Nitric Oxide Synthase Gene and Migraine. Int. J. Neurosci 2012, 123, 50–54. DOI: 10.3109/00207454.2012.724743Alaşehirli, B.; Akçalı, A.; Demiryürek, A.T.; Ö zel, A.; Erdal, M.E.; Neyal, M. Lack of Association Between the C276T Polymorphism of the Neuronal Nitric Oxide Synthase Gene and Migraine. Int. J. Neurosci 2012, 123, 50–54. DOI: 10.3109/00207454.2012.724743Ishii, M.; Yahara, М.; Katoh, Н.; Kawamura, М.; Shimizu, S. Polymorphisms of nitric oxide synthase and GTP cyclohy-drolase I genes in Japanese patients with medication overuse headaches. Neurol. Asia 2014, 19, 277–281.Ishii, M.; Yahara, М.; Katoh, Н.; Kawamura, М.; Shimizu, S. Polymorphisms of nitric oxide synthase and GTP cyclohy-drolase I genes in Japanese patients with medication overuse headaches. Neurol. Asia 2014, 19, 277–281.García-Martín, E.; Martinez, C.; Serrador, M.; Alonso-Navarro, H.; Navacerrada, F.; García-Albea, E.; Agundez, J.A.; JiménezJiménez, F.J. Neuronal Nitric Oxide Synthase (nNOS, NOS1) rs693534 and rs7977109 Variants and Risk for Migraine. Headache J. Head Face Pain 2015, 55, 1209–1217. DOI: 10.1111/head.12617García-Martín, E.; Martinez, C.; Serrador, M.; Alonso-Navarro, H.; Navacerrada, F.; García-Albea, E.; Agundez, J.A.; JiménezJiménez, F.J. Neuronal Nitric Oxide Synthase (nNOS, NOS1) rs693534 and rs7977109 Variants and Risk for Migraine. Headache J. Head Face Pain 2015, 55, 1209–1217. DOI: 10.1111/head.12617Levinsson, A.; Olin, A.-C.; Björck, L.; Rosengren, A.; Nyberg, F. Nitric oxide synthase (NOS) single nucleotide polymorphisms are associated with coronary heart disease and hypertension in the INTERGENE study. Nitric Oxide 2014, 39, 1–7. DOI: 10.1016/j.niox.2014.03.164Levinsson, A.; Olin, A.-C.; Björck, L.; Rosengren, A.; Nyberg, F. Nitric oxide synthase (NOS) single nucleotide polymorphisms are associated with coronary heart disease and hypertension in the INTERGENE study. Nitric Oxide 2014, 39, 1–7. DOI: 10.1016/j.niox.2014.03.164Geography of Genetic Variants Browser. Available online https://popgen.uchicago.edu/ggv/?data=%221000genomes%22&chr=12&pos=11777151 (accessed on 20 October 2022)Geography of Genetic Variants Browser. Available online https://popgen.uchicago.edu/ggv/?data=%221000genomes%22&chr=12&pos=11777151 (accessed on 20 October 2022)

The authors declare that there are no conflicts of interest present.